340B Program At ‘Critical Inflection Point,’ Oversight Agency Head Tells Providers
The head of the federal agency overseeing the 340B drug discount program offers unusually direct calls for legislative action during the safety net provider association winter conference. But is action likely in Congress any time soon?
